Company Description
Advanced Biomed is committed to the application research of integrating semiconductor technology and biotechnology.
Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services.
These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer.
We are a holding company incorporated in the State of Nevada. We operate through Advanced Biomed Inc. (Taiwan) and Advanced Biomed HK Limited.
Advanced Biomed Taiwan is responsible for the main operation and the design and development of the company's primary technologies and products.
| Country | Taiwan |
| Founded | 2014 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 38 |
| CEO | Hung To Pau, Ph.D. |
Contact Details
Address: 689-87 Xiaodong Road Yongkang District, Tainan Taiwan | |
| Phone | 886-6-3121716 |
| Website | advanbiomed.com |
Stock Details
| Ticker Symbol | ADVB |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0001941029 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Yi Lu, Ph.D. | Chairman of the Board, Chief Science Officer, and President |
| Hung To Pau, Ph.D. | Chief Executive Officer, director and Secretary |
| Mingze Yin | Chief Financial Officer and Treasurer |
| Steven I-Fang Cheng, Ph.D. | Chief Technology Officer |